金沙检测线路js95(中国)股份有限公司-Official website

You are about to leave Peijia Medical's official Chinese website.
You have just clicked on a link to another website. After clicking Continue, you may be taken to a website run by a third party. We are not responsible for the review and control of content outside Peijia Medical's official Chinese website, nor do we assume any responsibility for business transactions or matters conducted outside Peijia Medical's official Chinese website. The use of other websites is subject to the terms of use and privacy policies of those websites. Certain products or information found on other websites may not be approved for your region or country.
Cancel
Continue
Brief News on Innovation
Company News Brief News on Innovation
Brief News on Innovation
SmartWave LITHOTRIPSY VALVULOPLASTY TECHNOLOGY SHOWCASED AT TCT2024
2024.11.04
SmartWave LITHOTRIPSY VALVULOPLASTY TECHNOLOGY SHOWCASED AT TCT2024

In the trial exploring the effectiveness and safety of using the SmartWave lith···
THE 2-YEAR RESULTS OF ALIGN-AR TRIAL OF JENAVALVE Trilogy™ HEART VALVE SYSTEM WERE PRESENTED AT TCT2024
2024.11.01
THE 2-YEAR RESULTS OF ALIGN-AR TRIAL OF JENAVALVE Trilogy™ HEART VALVE SYST···

At 2 years, the cardiac mortality rate was still lower than the study’s prespec···
INTERPRETATION OF PRE-MARKET CLINICAL DATA FOR YonFlow® FLOW DIVERTER
2024.10.31
INTERPRETATION OF PRE-MARKET CLINICAL DATA FOR YonFlow® FLOW DIVERTER

During October 24-27, 2024, the pre-market clinical data for the YonFlow® flow ···
PROFESSOR WANG YANS TEAM AT XIAMEN UNIVERSITY CARDIOVASCULAR HOSPITAL SUCCESSFULLY COMPLETES THE FIRST ENROLLMENT IN THE CHINESE CLINICAL TRIAL CENTER FOR PEIJIA HighLife® TSMVR SYSTEM
2024.09.27
PROFESSOR WANG YANS TEAM AT XIAMEN UNIVERSITY CARDIOVASCULAR HOSPITAL SUCCE···

On September 24, 2024, led by President Wang Yan of Xiamen University Affiliate···
REGISTERED CLINICAL DATA OF TaurusElite® AND TaurusTrioTM DEBUT AT PCR-CCV 2024
2024.09.24
REGISTERED CLINICAL DATA OF TaurusElite® AND TaurusTrioTM DEBUT AT PCR-CCV ···

During September 20-22, 2024, Peijia presented multiple clinical data at the PC···
PEIJIA MEDICAL RECEIVES THE NMPA APPROVAL FOR THE REGISTRATION APPLICATION OF TaurusMax™ TAVR SYSTEM
2024.08.15
PEIJIA MEDICAL RECEIVES THE NMPA APPROVAL FOR THE REGISTRATION APPLICATION ···

Peijia Medical received the NMPA approval for the registration application of Ta···
HighLife® Transseptal Mitral Valve Replacement (TSMVR) System: Latest Updates Presented at New York Valves 2024, FDA Approved IDE Application to Initiate US Piovtal Study for Treatment of Mitral Regurgitation
2024.06.13
HighLife® Transseptal Mitral Valve Replacement (TSMVR) System: Latest Updat···

From June 5 to 7, 2024, the New York Valves (NYV) conference was held, where Pro···
MonarQ™ Transcatheter Tricuspid Valve Replacement (TTVR) Innovative Device: The Latest Results of the FIM Clinical Implantation Were Presented at New York Valves 2024
2024.06.13
MonarQ™ Transcatheter Tricuspid Valve Replacement (TTVR) Innovative Device:···

From June 5 to 7, 2024, the latest results of the FIM clinical implantation of M···
PEIJIA MEDICAL SHONE AT TWO MAJOR  STRUCTURAL HEART DISEASE  CONGRESSES TO DEMONSTRATE  INNOVATION
2024.04.22
PEIJIA MEDICAL SHONE AT TWO MAJOR STRUCTURAL HEART DISEASE CONGRESSES TO ···

On March 18-24 and April 15-20, 2024, Peijia Medical shone at the 5th China Stru···
NEW AV21 SPECIFICATION: PEIJIA MEDICAL’S TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) SYSTEM APPROVED BY THE NMPA
2024.04.19
NEW AV21 SPECIFICATION: PEIJIA MEDICAL’S TRANSCATHETER AORTIC VALVE REPLACE···

On April 18, 2024, new AV21 specification of TaurusOne® and TaurusElite® TAVR sy···
INNOVATIVE TRANSCATHETER EDGETO-EDGE REPAIR (TEER) SYSTEM GeminiOne®: RESULTS OF DMR TREATMENT PUBLISHED FOR THE FIRST TIME
2024.04.15
INNOVATIVE TRANSCATHETER EDGETO-EDGE REPAIR (TEER) SYSTEM GeminiOne®: RESU···

On April 12, 2024, the results of GeminiOne® for DMR were published in JACC: Cas···
Trilogy™ THV SYSTEM FOR AR INDICATION: RESULTS FROM ALIGN-AR PIVOTAL TRIAL WERE PUBLISHED IN THE LANCET
2024.03.29
Trilogy™ THV SYSTEM FOR AR INDICATION: RESULTS FROM ALIGN-AR PIVOTAL TRIAL ···

On March 26, 2024, the exciting results of JenaValve TrilogyTM System’s pivotal ···
Home < ···23456··· > Last
Top
XML 地图